Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-30

Clinical Trial Update: A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial in children and adolescents with newly diagnosed Type 1 diabetes assessing rapid-acting mealtime insulin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rapid-acting mealtime insulin

Snippet

Sponsor: Emory University | Conditions: Diabetes Mellitus, Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-09-30